Inflammatory cell populations and cytokine mRNA expression in the nasal mucosa in aspirin-sensitive rhinitis

European Respiratory Journal

Volumn 14, Issue 3, 1999, Pages 610-615

  Varga, E M ^a   Jacobson, M R ^a   Masuyama, K ^e   Rak, S ^b   Till, S J ^a   Darby, Y ^c   Hamid, Q ^d   Lund, V ^a   Scadding, G K ^c   Durham, S R ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c ROYAL NATIONAL THROAT NOSE AND EAR HOSPITAL   (United Kingdom)

^d MCGILL UNIVERSITY   (Canada)

^e NONE

Author keywords

Aspirin intolerance; Cytokines; Eosinophils; Mast cells; Rhinitis; T cells

Indexed keywords

ACETYLSALICYLIC ACID; CD3 ANTIGEN; CD68 ANTIGEN; IMMUNOGLOBULIN E; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG TOLERANCE; EOSINOPHILIA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; MALE; NOSE MUCOSA; PRIORITY JOURNAL; RHINITIS;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, CD; ASPIRIN; BIOPSY; BLOOD PROTEINS; CHYMASES; EOSINOPHIL GRANULE PROTEINS; FEMALE; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; INTERLEUKINS; LEUKOCYTES; MACROPHAGES; MALE; MAST CELLS; MIDDLE AGED; NASAL MUCOSA; RHINITIS, ALLERGIC, PERENNIAL; RIBONUCLEASES; RNA, MESSENGER; SERINE ENDOPEPTIDASES; TRYPTASES;

EID: 0032861685     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.1999.14c21.x     Document Type: Article

References (36)

1. Hirschberg, Mitteilung ueber einen Fall von Nebenwirkung des Aspirin. Dtsch Med Wochenschr 1902; i: 416.
2. Widal F, Abrami P, Lermoyez J. Anaphylaxie et idiosyncrasie. Presse Med 1922; 11: 105-111.
3. Samter M, Beers RF. Intolerance to aspirin: clinical studies and consideration of its pathogenesis. Ann Intern Med 1968; 68: 975-983.
4. Schlumberger HD. Drug induced pseudo-allergic syndrome as exemplified by acetylsalicylic acid intolerance. In: Dukor P, Kallos P, Schlumberger HD, et al., eds. Pseudo-Allergic Reactions. Involvement of Drugs and Chemicals. Vol 1. Basel, Karger, 1980; pp. 130.
5. Sczeklik A. Mechanism of aspirin-induced asthma. Allergy 1997; 52: 613-619.
6. Feireri NR, Howland WC, Stevenson DD, Spiegelberg HL. Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin. Am Rev Respir Dis 1988; 137: 847-854.
7. Pleskow WW, Stevenson DD, Mathison DA, Simon RA, Schatz M, Zeiger RS. Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization ofthe refractory period. J Allergy Clin Immunol 1982; 69: 11-19.
8. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971; 231: 232-235.
9. Szczeklik A, Gryglewski RJ, Czerniawska MG. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. BMJ 1975; 1: 67-69.
10. Cowburn AS, Sladek K, Soja J, et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998; 15: 101; 834-846.
11. Sanak M, Simon HU, Szczeklik A. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 1997; 350: 1599-1600.
12. Nasser SM, Pfister R, Christie PE, et al. Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects. Am J Respir Crit Care Med 1996; 153: 90-96.
13. Nasser S, Christie PE, Pfister R, et al. Effect of endobronchial aspirin challenge on inflammatory cells in bronchial biopsy samples from aspirin-sensitive asthmatic subjects. Thorax 1996; 51: 64-70.
14. Bosso JV, Schwartz LB, Stevenson DD. Tryptase and histamine release during aspirin-induced respiratory reactions. J Allergy Clin Immunol 1991; 88: 830-837.
15. Sladek K, Szczeklik A. Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. Eur Respir J 1993; 6: 391-399.
16. Daxun Z, Becker WM, Schulz KH, Schlaak M. Sensitivity to aspirin: a new serological diagnostic method. J Investig Allergol Clin Immunol 1993; 3: 72-78.
17. Zhu DX, Zhao JL, Mo L, Li HL. Drug allergy: identification and characterization of IgE-reactivities to aspirin and related compounds. J Investig Allergol Clin Immunol 1997; 7: 160-168.
18. Yamashita T, Tsuji H, Maeda N, Tomoda K, Kumazawa T. Etiology of nasal polyps associated with aspirin-sensitive asthma. Rhinol Suppl 1989; 8: 15-24.
19. Smith DM, Gerrard JM, Juhn SK, White JG. Arachidonic acid metabolism in nasal polyps and allergic inflammation. Minn Med 1981; 64: 605-610.
20. Bentley AM, Jacobson MR, Cumberworth V, et al. Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells. J Allergy Clin Immunol 1992; 89: 877-883.
21. Cameron L, Durham SR, Jacobson MR, et al. Expression of IL-4, Cε RNA and Iε RNA in the nasal mucosa of patients with seasonal rhinitis: effect of topical cortico-steroids. J Allergy Clin Immunol 1998; 101: 330-336.
22. Masuyama K, Till SJ, Jacobson MR, et al. Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: effect of topical corticosteroids. J Allergy Clin Immunol 1998; 102: 610-617.
23. Varga EM, Jacobsen MR, Till SJ, et al. Cellular infiltration and cytokine mRNA expression in perennial allergic rhinitis. Allergy 1999; 54: 338-345.
24. Varney VA, Jacobson MR, Sudderick RM, et al. Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T-lymphocytes, eosinophils and neutrophils. Am Rev Respir Dis 1992; 146: 170-176.
25. Durham SR, Ying S, Varney VA, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5 and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after allergen provocation: relationship to tissue eosinophilia. J Immunol 1992; 148: 2390-2394.
26. Sousa AR, Lams BE, Pfister R, Christie PE, Schmitz M, Lee TH. Expression of interleukin-5 and granulocytemacrophage colony-stimulating factor in aspirin-sensitive and non-aspirin-sensitive asthmatic airways. Am J Respir Crit Care Med 1997; 156: 1384-1389.
27. Maestrelli P, Del Prete PG, De Carli CM, et al. CD8 T-cell clones producing interleukin-5 and interferon-gamma in bronchial mucosa of patients with asthma induced by toluene diisocyanate. Scand J Work Environ Health 1994; 20: 376-381.
28. Bradding P, Feather IH, Wilson S, et al. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J Immunol 1993; 151: 3853-3865.
29. Blom HM, Godhelp T, Fokkens WJ, et al. Mast cells, eosinophils and IgE-positive cells in the nasal mucosa of patients with vasomotor rhinitis. An immunohistochemical study. Eur Arch Otorhinolaryngol Suppl 1995; 1: S33-S39.
30. Rasp G, Thomas PA, Bujia J. Eosinophil inflammation of the nasal mucosa in allergic and non-allergic rhinitics measured by eosinophil cationic protein levels in native nasal fluid and serum. Clin Exp Allergy 1994; 24: 1151-1156.
31. Elwany S, Bumsted R. Ultrastructural observations on vasomotor rhinitis. Otorhinolaryngol Relat Spec 1987; 49: 199-205.
32. Ying S, Durham SR, Barkans J, et al. T cells are the principal source of interleukin-5 mRNA in allergen-induced rhinitis. Am JRespir Cell Mol Biol 1993; 9: 356-360.
33. Ying S, Humbert M, Barkans J, et al. Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CDS+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and non-atopic (intrinsic) asthmatics. J Immunol 1997; 158: 3539-3544.
34. Hamilos DL, Leung DY, Wood R, et al. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol 1995; 96: 537-544.
35. Drazen JM, Israel E, O'Byrne PM. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999; 340: 197-206.
36. Griffin M, Weiss JW, Leitch AG, et al. Effects of leukotriene D on the airways in asthma. N Engl J Med 1983; 308: 436-439.